Sitemap

June 03, 2012 Articles

Filter by Available Specialty
  1. Continuation of bevacizumab with second-line chemotherapy extends survival in patients with metastatic colorectal cancer
  2. Investigational agent significantly improved PFS in patients with HER-2–positive advanced breast cancer